🌍【Merging Dermatology & Innovation】

—— Highlights from TDAC × AMWC Asia × ASDS Spring Congress
 

This week, we joined the annual Spring Dermatology Congress, co-organized by the Taiwan Dermatological Association (TDAC) and AMWC Asia, and for the first time, in collaboration with the Asian Society for Dermatologic Surgery (ASDS). The conference brought together an impressive range of academic and industry leaders across dermatology and aesthetic medicine.

 

Dr. Chau Yee Ng from our center delivered a talk on “AI and Skin Imaging Trends in Pigmentary Disorders,” exploring how evidence-based AI applications can enhance treatment evaluation accuracy and workflow efficiency for pigmentary conditions in clinical practice.

At the Innovation Hub, we also introduced EI-001, our novel biologic candidate under development for vitiligo. We shared its origin story, clinical vision, and current trial progress—highlighting its potential to unlock new treatment possibilities for pigmentary disorders.

 

The congress also showcased cutting-edge devices, lasers, and next-generation skincare technologies—each advancing with science-backed validation. It was an inspiring convergence of clinical practice and scientific innovation.

We're excited to keep bridging the gap between dermatology and aesthetics, and to continue turning research into tangible impact for patients.